Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trialCharu Aggarwal, Nehal J. Lakhani, Scott Antonia et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 140
Hypoxia-inducible factor-1α mediates the toll-like receptor 4 signaling pathway leading to anti-tumor effects in human hepatocellular carcinoma cells under hypoxic conditionsXiaoyu Zhang, Changwei Zhou|Oncology Letters|2016Cited by 16